Ulalo develops AI-powered infrastructure to help healthcare organizations identify and engage eligible patients for clinical trials.
Ulalo is building AI-powered infrastructure that helps healthcare organizations identify and engage eligible patients for clinical research while improving diversity, operational efficiency, and regulatory readiness. The company addresses the clinical trial recruitment problem where patient identification remains one of the slowest, most expensive, and least equitable parts of bringing new therapies to market, with 80% of clinical trials facing enrollment delays.